Evidence map›Paper›PMID 41659852›Full record

ArticleFrontiers in immunology2026

Identification and characterization of novel antimicrobial peptides from

Wafa Al-Mamari, Yasmin Elhag, Samir Al Bulushi, Rokeya S Rekha, Cecilia Mörman, Peter Bergman, Aliya Al-Ansari, Salma Al-Adwani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wafa Al-MamariDepartment of Biology, College of Science, Sultan Qaboos University, Muscat, Oman.
Yasmin ElhagDepartment of Animal & Veterinary Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Muscat, Oman.
Samir Al BulushiAnimal Research Center, Directorate General of Veterinary Services, Royal Court Affairs, Muscat, Oman.
Rokeya S RekhaDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.
Cecilia MörmanDepartment of Medicine, Karolinska Institutet, Huddinge, Sweden.
Peter BergmanDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.
Aliya Al-AnsariDepartment of Biology, College of Science, Sultan Qaboos University, Muscat, Oman.
Salma Al-AdwaniDepartment of Animal & Veterinary Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Muscat, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an urgent need for new antimicrobial agents to address the emerging antimicrobial resistance and the lack of novel antibiotics on the market. Antimicrobial peptides (AMPs) have gained significant interest as potential antibiotics over the past 30 years due to their broad activity against bacteria. So far, the presence, characteristics, and function of AMPs in camel immunity remain to be explored. Therefore, this study aims to identify and functionally characterize AMPs in

Indexed as

Antimicrobial Cationic PeptidesAntimicrobial PeptidesCamelusAmino Acid SequenceAnimalsAnti-Bacterial AgentsCathelicidinsComputational BiologyHemolysisHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesCathelicidinsantimicrobial peptidebioinformaticsCamelus dromedariuscathelicidinmultidrug resistance

Identifiers

PMID41659852
PMCPMC12872550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.